ValiRx plc

LSE (GBp): ValiRx plc (VAL)

Last Price

0.331

Today's Change

-0.014 (4.05%)

Day's Change

0.33 - 0.36

Trading Volume

478,622

Overview

Market Cap

1 Million

Shares Outstanding

374 Million

Avg Volume

16,415,728

Avg Price (50 Days)

0.36

Avg Price (200 Days)

0.48

PE Ratio

-0.34

EPS

-0.01

Earnings Announcement

10-Jun-2026

Previous Close

0.34

Open

0.33

Day's Range

0.33 - 0.36

Year Range

0.22 - 0.875

Trading Volume

478,622

Price Change Highlight

1 Day Change

0.00%

5 Day Change

-1.43%

1 Month Change

-16.87%

3 Month Change

46.81%

6 Month Change

-42.50%

Ytd Change

-5.48%

1 Year Change

-48.89%

3 Year Change

-96.58%

5 Year Change

-98.59%

10 Year Change

-97.70%

Max Change

-99.99%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company's lead drug candidates include VAL201, a small molecule that has completed Phase I/II trials for the treatment of prostate cancer and other hormone associated solid tumours comprising breast and ovarian cancer; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of non-small cell lung cancer. Its drug candidates also comprise VAL301, a peptide ingredient that in pre-clinical development for the treatment of women with endometriosis; and BC201, a combination of the peptide ingredient of VAL201/VAL301 with complementary active components for the treatment for patients suffering severe symptoms of Covid-19. ValiRx plc was incorporated in 2000 and is based in Hatfield, the United Kingdom.

Discussions
Be the first to like this. Showing 0 of 0 comments

{uid}

{comment}

Just now

Post a Comment